U.S. Personal Products Stock News

For investors wondering whether MKS at around US$253 a share is still a worthwhile entry, or if most of the value is already on the table, this article walks through what the numbers currently suggest. The stock has been volatile over different time frames, with a 2.7% decline over the last 7 days, a 16.9% return over 30 days, a 50.7% return year to date and a 155.8% return over the past year, while the 3 year and 5 year returns sit at 182.0% and 53.5% respectively. Recent coverage around...

Steel Dynamics, together with SGH Ltd, has submitted a revised joint bid to acquire BlueScope Steel's North American operations. The proposed deal would enlarge Steel Dynamics' North American presence in flat-rolled and value-added steel products. Corporate Knights has again named Steel Dynamics as the global leader in steel industry sustainability, reflecting its circular manufacturing model. For investors watching NasdaqGS:STLD, these updates come as the stock trades around $196.01, with...

Wondering whether Innospec's current share price still reflects its underlying worth, or if the market is mispricing it, is a fair question for anyone tracking specialty chemicals stocks. Over the past week the stock has recorded a 8.8% decline, with a 2.3% decline over 30 days, a 3.5% gain year to date, and a 20.9% decline over one year, while the three and five year returns stand at 25.8% and 16.4% declines respectively. These moves have kept Innospec on the radar of investors who are...

CRH (NYSE:CRH) completed more than three dozen acquisitions in 2025. The company acquired Eco Material Technologies, described as a transformative deal for its portfolio. Management is preparing for expected strength in U.S. infrastructure spending in 2026, including state and federal highway projects. CRH, a major player in construction materials and solutions, is using acquisitions to build out its U.S. footprint and broaden its mix of products and services. The Eco Material Technologies...

Capricor Therapeutics recently advanced its lead candidate Deramiocel into phase 3 trials for Duchenne muscular dystrophy while progressing preclinical work on its exosome-based SARS-CoV-2 vaccine and StealthX exosome platform. This pipeline momentum, coupled with unanimous positive analyst coverage, highlights how central Deramiocel and exosome technologies have become to the company’s long-term thesis. Next, we’ll examine how Deramiocel’s phase 3 progress and upbeat analyst sentiment feed...

T. Rowe Price Group (TROW) has attracted fresh attention after recent share price weakness, with the stock showing negative returns over the month and past 3 months. This has prompted investors to reassess its current valuation and fundamentals. See our latest analysis for T. Rowe Price Group. At a share price of $93.06, T. Rowe Price Group has seen a 1 day share price return of 2.43% decline and a 30 day share price return of 11.90% decline, while its 1 year total shareholder return of 8.04%...

If you are wondering whether Brown-Forman is fairly priced or offering value right now, this article walks through the key numbers that matter. The share price closed at US$30.20 most recently, with returns of 0.8% over 7 days, 9.5% over 30 days and 15.5% year to date, compared with a 5.2% decline over 1 year, a 50.8% decline over 3 years and a 54.3% decline over 5 years. Recent coverage of Brown-Forman has focused on how the spirits group is positioned in the branded alcohol market and how...

If you are wondering whether Ternium's current share price gives you good value, this article walks through what the numbers actually say and how that lines up with different valuation methods. Ternium's stock closed at US$43.33, with a 1 year return of 59.4% and a 5 year return of 96.2%. This comes even though the shares show a 0.7% decline over 7 days, a 1.1% decline over 30 days, and a 10.7% gain year to date. Recent coverage has put a spotlight on how investors are weighing steel demand,...

If you are wondering whether Tenet Healthcare's current share price lines up with its underlying value, this article is designed to walk you through that question step by step. Tenet Healthcare's stock last closed at US$233.77, with returns of 1.2% over 7 days, 23.8% over 30 days, 17.2% year to date, 77.7% over 1 year and 299.3% over 3 years. These figures can change how investors think about both upside and risk. Recent news around Tenet Healthcare has focused on its role in the US hospital...

With Manchester United stock trading at around US$17.40, this article considers whether that price represents a bargain or reflects the club's famous name, and explores what the current market valuation might be implying about the club's overall worth. The share price has been relatively steady in the very short term, with a 0.2% decline over the last 7 days, a 1.3% gain over 30 days, and returns of 10.3% year to date and 18.0% over the past year, compared with weaker figures over 3 and 5...

If you are wondering whether Teva Pharmaceutical Industries is still good value after its recent run, this article walks through what the current share price might be implying about the company. Teva's share price last closed at US$33.91, with returns of 6.6% over the past 30 days, 9.6% year to date and 102.1% over the last year. The 3 year and 5 year returns sit at 242.5% and 210.5% respectively, which raises the question of how much optimism is already reflected in the price. Recent...

AMC Entertainment Holdings (AMC) just posted its FY 2025 numbers with Q4 revenue of US$1,288.3 million, a basic EPS loss of US$0.25, and net income excluding extra items showing a loss of US$127.4 million, while trailing 12 month figures sit at US$4.8 billion of revenue, a basic EPS loss of US$1.34, and a net loss of US$632.4 million. Over recent quarters, the company has seen quarterly revenue move from US$862.5 million in Q1 2025 to between roughly US$1.3 billion and US$1.4 billion through...

If you are wondering whether HF Sinclair is still good value after its recent run, or if the price already reflects most of the story, this article will walk you through what the current share price could be implying. The stock recently closed at US$49.59, with a 7 day return of 15.3% decline, a 30 day return of 0.8% decline, a 1 year return of 41.1% and a 5 year return of 50.6%. These moves sit against a backdrop of ongoing interest in US energy stocks, where investors have been weighing...

If you are wondering whether Provident Financial Services is offering fair value at around US$21.93 per share, you are not alone. This article will walk through what that price really implies. The stock has seen mixed returns recently, with a 4.5% decline over the last 7 days, a 6.5% gain over the last 30 days, 11.0% year to date, and 29.8% over the past year, while the 3 year and 5 year returns sit at 9.9% and 36.1% respectively. Recent news flow around regional banks and funding conditions...

Edison International (NYSE:EIX) has introduced a Wildfire Recovery Compensation Program for Eaton Fire victims. The program aims to provide compensation to tens of thousands of affected residents and businesses. The announcement comes as the company continues to face wildfire related legal and financial liabilities. Edison International, the parent company of Southern California Edison, operates as a regulated electric utility and is closely tied to wildfire risk across its service...

CTS Corporation recently reported past full-year 2025 results showing higher sales and net income than the prior year, reaffirmed 2026 sales guidance of US$550 million–US$580 million, and declared a US$0.04 per-share cash dividend payable on April 24, 2026 to shareholders of record on March 27, 2025. Alongside these results, CTS highlighted strong cash generation, active share repurchases, and an intention to pursue acquisitions while continuing to return cash to shareholders. Next, we'll...

Recent performance snapshot for Union Pacific Union Pacific (UNP) has drawn investor attention after a strong month, with the stock showing a 14.9% return over the period and a similar gain over the past 3 months. Those moves come alongside reported annual revenue of US$24.51b and net income of US$7.14b. These figures give investors fresh numbers to weigh against the railroad operator’s recent share price performance. See our latest analysis for Union Pacific. The recent 14.9% 1 month share...

The Morning Bull - US Market Morning Update Tuesday, Feb, 24 2026 US stock futures are slightly softer this morning, with S&P 500 contracts edging lower as investors weigh higher borrowing costs and trade noise. The US 10 year Treasury yield sits around 4.05%, which means interest rates on everything from mortgages to corporate debt remain relatively high. At the same time, trade headlines, including talk of a 15% tariff plan and related legal disputes, are keeping global supply chains and...

Recent performance snapshot Burlington Stores (BURL) has drawn fresh attention after a period of strong multi year total returns. The stock recently closed at US$311.38 and has shown gains over the past month and over the past 3 months. See our latest analysis for Burlington Stores. That recent 24.73% 3 month share price return and 31.99% 1 year total shareholder return suggest momentum has been building around Burlington Stores, even with a small 1 day pullback at US$311.38. If this kind of...

Wondering if Upstart Holdings at around US$27.26 is a bargain or a value trap? This article walks through what the numbers actually say about the stock. The share price has seen sharp moves recently, with an 11.1% decline over the last 7 days, a 39.8% decline over the last 30 days, and year to date returns of 40.5% in the red, even though the 3-year return sits at 49.4%. These swings sit against a backdrop where Upstart remains a watched name in AI driven lending, with investors reacting to...

What JBG SMITH’s Latest Figures Tell You JBG SMITH Properties (JBGS) has attracted fresh attention as investors weigh its recent share performance, mixed revenue and net income trends, and the current discount implied by analyst expectations. See our latest analysis for JBG SMITH Properties. Recent moves in JBG SMITH’s share price, with a 1-day share price return of 0.96% contrasted against a 30-day share price return of a 7.58% decline and a 90-day share price return of a 13.06% decline,...

If you are wondering whether Karman Holdings at around US$81.27 still offers value after a strong run, this article will walk through what the current price might be implying. The stock has had a mixed ride recently, with a 7 day return of 7.2%, a 30 day return of 24.9% decline, a 1 year return of 176.6%, and a year to date return of 5.8%. That kind of swing often follows shifting expectations around the business or its sector. Karman Holdings is on many investors' radars as a result. This...

If you are wondering whether EnerSys is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about its value. The stock last closed at US$167.42, with returns of 11.1% year to date and 67.4% over the past year, even though the past 7 days and 30 days showed declines of 6.6% and 3.5%. Recent coverage around EnerSys has focused on its role in stored energy solutions and how investors are thinking about battery and power...

The U.S. Supreme Court’s decision to invalidate certain tariffs has direct implications for Signet Jewelers (SIG). The company sources about half its merchandise from India, which reduces its tariff exposure from 15.1% to 0%. See our latest analysis for Signet Jewelers. Despite the tariff ruling, Signet’s share price has been choppy, with a 4.9% 7 day share price return and a 5.2% 30 day share price return. Its 1 year total shareholder return of 88.4% highlights earlier, much stronger...